Blaie et al. showed that a granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cell vaccine (GVAX) induces intratumoral T cell infiltration, leading to the activation of the tumor microenvironment. This evidence concerns the gene CSF2 and neoplasm.